This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Cubist Pharmaceuticals Inc
CBST : NASDAQ : Health Care
$66.55 -0.55 | -0.82%
Today's Range: 66.25 - 67.54
Avg. Daily Volume: 705,600
09/19/14 - 4:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
CBST CUBIST PHARMACEUTICALS INC 68.43 5182.41 3421.50 1121.37 15.27
ITMN INTERMUNE INC 73.70 7982.67 n/m 111.42 173.85
MDVN MEDIVATION INC 96.77 7430.87 358.41 391.92 79.56
ICPT INTERCEPT PHARMA INC 292.85 6213.69 n/m 1.66 -4.43
UTHR UNITED THERAPEUTICS CORP 122.38 5784.78 24.00 1203.45 18.91
ALNY ALNYLAM PHARMACEUTICALS INC 70.37 5373.10 n/m 35.41 -32.67
SGEN SEATTLE GENETICS INC 40.90 5049.02 n/m 274.96 12.39
ISIS ISIS PHARMACEUTICALS INC 40.87 4811.83 n/m 151.07 33.77
OPK OPKO HEALTH INC 8.62 3699.67 n/m 87.15 4.68
NPSP NPS PHARMACEUTICALS INC 32.70 3484.58 1635.00 193.82 66.88
CPHD CEPHEID INC 43.67 3065.98 n/m 436.75 21.03
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

CBST Ind Avg S&P 500
3421.50 86.69 19.81
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs